Loading clinical trials...
Loading clinical trials...
Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group, Polysomnography Study to Assess the Efficacy and Safety of ACT-541468 in Adult and Elderly Subjects With Insomnia Disorder
Conditions
Interventions
Daridorexant 25 mg
Daridorexant 50 mg
+1 more
Locations
81
United States
Pinnacle Research Group, LLC
Anniston, Alabama, United States
Pulmonary Associates of the Southeast/WCR
Birmingham, Alabama, United States
Preferred Research Partners, Inc
Little Rock, Arkansas, United States
Woodland Research Northwest
Rogers, Arkansas, United States
Marvel Clinical Research
Huntington Beach, California, United States
Long Beach Clinical Trials
Long Beach, California, United States
Start Date
June 4, 2018
Primary Completion Date
January 25, 2020
Completion Date
February 25, 2020
Last Updated
March 25, 2022
NCT05780177
NCT06779149
NCT07028697
NCT07337369
NCT06955299
NCT04573725
Lead Sponsor
Idorsia Pharmaceuticals Ltd.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions